miR-200c can directly target the 3’-UTR of TUBB3 mRNA, resulting in post-transcriptional suppression of TUBB3 expression [23], thereby improving sensitivity of paclitaxel, vincristine, and other drugs in tumor cells. This evidence concerns the gene TUBB3 and neoplasm.